AILINCOM 
SalusThe United States has approved the first direct-acting drug for the treatment of late-stage pancreatic adenocarcinoma, one of the most aggressive forms of cancer. The new medication has demonstrated a twofold improvement in survival rates compared to standard chemotherapy.
SalusThe United States continues to experience a shortage of sterile materials used in neurosurgery, a situation that may persist until the end of 2026. Medical institutions are advised to use their supplies sparingly and reserve them for critical surgeries.
SalusThe head of the FDA's Office of Vaccines and Biotechnological Products, Dr. Vinay Prasad, will leave the agency at the end of April. A search for his successor is currently underway.
SalusA new large-scale study has shown that a brain stimulation device approved for treating ADHD in children is safe, but did not produce significant improvement in symptoms compared to a placebo. The authors emphasize the importance of rigorous clinical trials before the widespread adoption of such methods.